Cas:109216-60-6 Methyl-N-methyl-indazole-3-carboxylate manufacturer & supplier

Chemical Name:Methyl-N-methyl-indazole-3-carboxylate

CAS.NO:109216-60-6

Synonyms:METHYL 1-METHYL-3-INDAZOLECARBOXYLATE;1H-Indazole-3-carboxylic acid, 1-methyl-, methyl ester;Methyl-N-methyl-indazole-3-carboxylate;1H-Indazole-3-carboxylicacid,1-methyl-,methyl ester;1-methyl-1H-indazole-3-carboxylic acid methyl ester;Methyl-1-methylindazole-3-carboxylate;Methyl-N-methyl-indozole-3-carboxylate;Methyl 1-methyl-1H-indazole-3-carboxylate;1-Methyl-1H-indazol-3-carbonsaeure-methylester

Molecular Formula:C₁₀H₁₀N₂O₂

Molecular Weight:190.199

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:313.1±15.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.596

PSA:44.12000

Exact Mass:190.074234

LogP:1.71

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like METHYL 1-METHYL-3-INDAZOLECARBOXYLATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Methyl-1H-indazol-3-carbonsaeure-methylester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl-1-methylindazole-3-carboxylate Use and application,Methyl-N-methyl-indazole-3-carboxylate technical grade,usp/ep/jp grade.

Related News: A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. 3-[4-(3-aminopropylamino)butylamino]propylazanium,chloride manufacturers Wavelength Pharmaceuticals will pay an undisclosed sum to buy up a majority stake in Hyderabad’s Vanamali Organics, an Indian firm specializing in making drug intermediates and starting materials that will add to Wavelengths’ API contract manufacturing work, the company said in a release. 2H-3,1-Benzoxazine-2,4(1H)-dione, 1-[4-(phenylmethoxy)phenyl]- suppliers As part of the strategy, the government will review the research funding offer to retain, attract and support the very best researchers, innovators and their teams. Octacosanoic acid, 26-methyl-, (26S)- vendor & factory There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17%,A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market.